Also known as biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes.
Public filings matched to Biogen across SEC, IRS, DOL and international registers — newest first.
Cross-referenced from the LPbacked Signal Feed.
Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.
Biogen is a corporate investor based in Cambridge, United States, managing approximately $28.0B in assets.
Biogen is headquartered in Cambridge, United States.
Biogen manages approximately $28.0B in assets under management.
Biogen was founded in 1978.
Biogen focuses on Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General), Biotechnology, Healthcare, Healthcare Specialists.
Verified contact details, key decision-makers, and investment preferences for Biogen are available on LPbacked. Create a free account to access them.